✦ LIBER ✦

Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin

✍ Scribed by Vernon J. Harvey; Dr. Maurice L. Slevin; Bruce A. J. Ponder; Anthony J. Blackshaw; Peter F. M. Wrigley

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 337 KB
Volume: 54
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840915)54:6<961::aid-cncr2820540602>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase II trial of combined

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

✍ Sébastien Kasseyet; Philippe Astoul; Christian Boutin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## BACKGROUND. Malignant pleural mesothelioma is associated with a poor prognosis because of its resistance to treatment. The authors conducted a Phase II trial in which two drugs (etoposide and 5-fluorouracil) were added to the Cancer and Leukemia Group B cisplatin-mitomycin regimen in an effort t

Phase II trial of 5-fluorouracil, adriam

Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma

✍ R. M. Bukowski; L. P. Schacter; C. W. Groppe; J. S. Hewlett; J. K. Weick; R. B. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Activity of doxorubicin and cisplatin co

Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study

✍ A. Ardizzoni; R. Rosso; V. Fusco; M. C. Pennucci; L. Santi; F. Salvati; A. Cinqu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Phase II trial of chemotherapy with 5-fl

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or